January 8, 2025
Worldwide experts release clinical recommendations for management of ATM cancer risk
Researchers established decades ago that ataxia-telangiectasia mutated (ATM) heterozygotes are at an increased risk for cancer, there remains a need to provide clear guidance for clinicians.
By Tom Wilemon